会计年度:2015-12-31收入分布
|
| 项目名称 | 主营业务收入 | 主营业务成本 | 主营业务毛利 | 毛利率 |
| 医药制造业 | 768,263,801.92 | 146,753,370.34 | 621,510,431.58 | 80.90 |
|
会计年度:2015-06-30
|
| 项目名称 | 主营业务收入 | 主营业务成本 | 主营业务毛利 | 毛利率 |
| 醋酸去氨加压素注射液 | 14,117,206.78 | 7,961,585.03 | 6,155,621.75 | 43.60 |
| 固体类 | 1,261,188.03 | 1,835,998.34 | -574,810.31 | -45.58 |
| 国外 | 56,856,737.71 | 9,397,325.99 | 47,459,411.72 | 83.47 |
| 华北区 | 87,875,441.50 | 11,892,448.16 | 75,982,993.34 | 86.47 |
| 华东区 | 31,525,183.81 | 7,044,808.33 | 24,480,375.48 | 77.65 |
| 华南区 | 21,608,772.10 | 5,731,313.19 | 15,877,458.91 | 73.48 |
| 华西区 | 19,370,220.64 | 13,195,344.95 | 6,174,875.69 | 31.88 |
| 华中区 | 47,853,224.62 | 10,303,813.36 | 37,549,411.26 | 78.47 |
| 客户肽 | 41,884,700.76 | 4,960,280.14 | 36,924,420.62 | 88.16 |
| 其他制剂 | 16,158,551.72 | 11,318,247.40 | 4,840,304.32 | 29.96 |
| 其中：注射用胸腺五肽 | 51,602,320.29 | 6,247,627.04 | 45,354,693.25 | 87.89 |
| 器械类 | 14,835,213.71 | 2,379,356.68 | 12,455,857.03 | 83.96 |
| 药品组合包装产品 | 9,479,102.64 | 3,172,251.93 | 6,306,850.71 | 66.53 |
| 医药制造业 | 265,089,580.38 | 57,565,053.98 | 207,524,526.40 | 78.28 |
| 原料药 | 15,794,642.83 | 4,767,500.97 | 11,027,141.86 | 69.82 |
| 制剂 | 181,834,732.41 | 40,449,665.92 | 141,385,066.49 | 77.75 |
| 注射用生长抑素 | 49,340,985.20 | 13,981,746.22 | 35,359,238.98 | 71.66 |
| 注射用特利加压素 | 50,615,668.42 | 940,460.23 | 49,675,208.19 | 98.14 |
|
会计年度:2014-12-31
|
| 项目名称 | 主营业务收入 | 主营业务成本 | 主营业务毛利 | 毛利率 |
| 医药制造业 | 417,185,948.63 | 71,965,663.93 | 345,220,284.70 | 82.75 |
|
会计年度:2014-06-30
|
| 项目名称 | 主营业务收入 | 主营业务成本 | 主营业务毛利 | 毛利率 |
| 醋酸去氨加压素注射液 | 13,410,043.39 | 5,119,617.74 | 8,290,425.65 | 61.82 |
| 国外 | 3,282,477.99 | 1,407,357.46 | 1,875,120.53 | 57.13 |
| 华北区 | 29,980,774.36 | 3,690,525.97 | 26,290,248.39 | 87.69 |
| 华东区 | 35,060,139.73 | 3,017,421.57 | 32,042,718.16 | 91.39 |
| 华南区 | 24,429,795.64 | 4,210,804.76 | 20,218,990.88 | 82.76 |
| 华西区 | 44,740,424.72 | 8,180,600.15 | 36,559,824.57 | 81.72 |
| 华中区 | 18,648,987.97 | 4,779,387.51 | 13,869,600.46 | 74.37 |
| 客户肽 | 2,569,101.94 | 1,358,189.49 | 1,210,912.45 | 47.13 |
| 其他制剂 | 1,952,862.28 | 1,192,021.16 | 760,841.12 | 38.96 |
| 其中：注射用胸腺五肽 | 66,433,507.89 | 11,261,224.94 | 55,172,282.95 | 83.05 |
| 医药制造业 | 156,142,600.41 | 25,286,097.42 | 130,856,502.99 | 83.81 |
| 制剂 | 153,573,498.47 | 23,927,907.93 | 129,645,590.54 | 84.42 |
| 注射用生长抑素 | 19,572,794.09 | 5,824,553.66 | 13,748,240.43 | 70.24 |
| 注射用特利加压素 | 52,204,290.82 | 530,490.43 | 51,673,800.39 | 98.98 |
|
会计年度:2013-12-31
|
| 项目名称 | 主营业务收入 | 主营业务成本 | 主营业务毛利 | 毛利率 |
| 医药制造业 | 299,919,474.92 | 46,210,056.39 | 253,709,418.53 | 84.59 |
|
3/5 转到 
